Inventprise (United States)

Recent papers from Inventprise (United States)

1. Novel non-aqueous rotavirus vaccine: Formulated for thermostability and easy administrationHuman Vaccines & Immunotherapeutics · 2026
2. Analytical Characterization of Pneumococcal Vaccine Conjugates Using SEC-MALS TechniqueMethods and Protocols · 2026
3. Automation of Polysaccharide Quantification: A Rapid High-Throughput Assay Enabled by Liquid Handling TechnologyBioTech · 2026
4. Development of a Novel Shigella Quadrivalent Conjugate Vaccine Using Shigella O-Polysaccharide and IpaB Carrier ProteinSHILAP Revista de lepidopterología · 2026
5. Safety and immunogenicity of a 25-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive healthy adults: Results from 2 randomised, controlled clinical trialsVaccine · 2026
6. Preclinical immunogenicity studies of Haemophilus influenzae type a glycoconjugate vaccineVaccine · 2026
7. Compatibility and Stability of a Shigella Polysaccharide—Protein Conjugate Antigen Formulated with Aluminum Salt and CpG 1018® AdjuvantsVaccines · 2025
8. Evaluation of Cholera Toxin B Subunit as a Novel Carrier Protein for Polysaccharide Conjugate VaccinesVaccines · 2025
9. Evaluation of Cholera Toxin B Subunit as a Novel Carrier Protein for Polysaccharide Conjugate VaccinesVaccines · 2025
10. Preclinical Immunogenicity of a 6-Valent GBS Glycoconjugate Vaccine from a Repeat-Dose GLP Toxicology StudyVaccines · 2025
11. The development of functional opsonophagocytic assays to evaluate antibody responses to Klebsiella pneumoniae capsular antigensmSphere · 2025
12. SARS-CoV-2 conjugate vaccine elicits robust immune responses that can protect against evolving variants.Vaccine · 2025
13. Multi-valent pneumococcal conjugate vaccine for global health: From problem to platform to productionHuman Vaccines & Immunotherapeutics · 2022
14. Mediator subunit Med15 dictates the conserved “fuzzy” binding mechanism of yeast transcription activators Gal4 and Gcn4Nature Communications · 2021